The Analyst Verdict: BrightSpring Health In The Eyes Of 7 Experts

In the preceding three months, 7 analysts have released ratings for BrightSpring Health BTSG, presenting a wide array of perspectives from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $23.0, a high estimate of $30.00, and a low estimate of $20.00. Observing a 21.05% increase, the current average has risen from the previous average price target of $19.00.

Breaking Down Analyst Ratings: A Detailed Examination

The standing of BrightSpring Health among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to BrightSpring Health. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of BrightSpring Health compared to the broader market.
• Price Targets: Understanding forecasts, analysts offer estimates for BrightSpring Health's future value. Examining the current and prior targets provides insight into analysts' changing expectations.

For valuable insights into BrightSpring Health's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on BrightSpring Health analyst ratings.

All You Need to Know About BrightSpring Health

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.

A Deep Dive into BrightSpring Health's Financials

Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: BrightSpring Health's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 28.82%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: BrightSpring Health's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -0.28%, the company may face hurdles in effective cost management.

Return on Equity (ROE): BrightSpring Health's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.51%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): BrightSpring Health's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.14%, the company may face hurdles in achieving optimal financial returns.

Debt Management: BrightSpring Health's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.83.

What Are Analyst Ratings?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.